Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2016 Feb;68(2):195–202. doi: 10.1002/acr.22651

Figure 1.

Figure 1

Differences in the scores of clinical indices of LN-activity with high vs. moderate/low LN-activity by kidney biopsy

†Values are means and SE; p-values based on test-tests comparing means of Lupus Nephritis Clinical Indices for low versus high NIH AI Score and TIAI Score, with cut-offs defined in the table

† LN-activity NIH-AI high vs. moderate/low is defined based on NIH-AI scores > 10 vs. ≤ 10

‡ LN-activity TIAI high vs. moderate/low is defined based on TIAI scores > 5 vs. ≤ 5

* Not significant